InsiderSignalSign in

← Insider buys

PAHC

Phibro Animal Health Corporation · Healthcare

Insiders bought $318K of Phibro Animal Health Corporation in the last 12 months

1 insider bought on 1 day.

$318KBought, 12 mo

$24.1MSold, 12 mo

$1.6BMarket cap

PAHC over the last year

Insider buy filed (1 day)

Largest buyers, last 12 months

E Thomas CorcoranDirector · 1 day$318K

PAHC after insider buys

3 months after each buy, from the first price a copier could get.

+17.2%Average

+12.8 ptsVs S&P 500

3 of 3Higher

3 buys since 2019 with 3 months of prices.

Every filing

148 insider filings since 2016, newest first

E Thomas Corcoran · Director

$318K+31.8%Jun 2

Jack Bendheim · President, CEO and 10% owner

$1.0M−20.0%May 7

Jack Bendheim · President, CEO and 10% owner

$1.1M−19.0%Apr 30

Jack Bendheim · President, CEO and 10% owner

$1.2M−16.0%Apr 23

Jack Bendheim · President, CEO and 10% owner

$1.2M−14.0%Apr 16

Jack Bendheim · President, CEO and 10% owner

$757K−20.0%Mar 31

Jack Bendheim · President, CEO and 10% owner

$1.2M−23.0%Mar 26

Jack Bendheim · President, CEO and 10% owner

$1.2M−20.0%Mar 19

Jack Bendheim · President, CEO and 10% owner

$258K−4.0%Mar 16

Jack Bendheim · President, CEO and 10% owner

$1.1M−54.0%Feb 26

Jack Bendheim · President, CEO and 10% owner

$716K−26.0%Feb 23

Jack Bendheim · President, CEO and 10% owner

$728K−21.0%Feb 18

Jack Bendheim · President, CEO and 10% owner

$3.7M−52.0%Feb 11

Jack Bendheim · President, CEO and 10% owner

$5.4M−44.0%Feb 9

Jack Bendheim · President, CEO and 10% owner

$545K−17.0%Feb 5

Jack Bendheim · President, CEO and 10% owner

$540K−22.0%Feb 2

Jack Bendheim · President, CEO and 10% owner

$50K−2.0%Jan 27

Jack Bendheim · President, CEO and 10% owner

$1.2M−45.0%Jan 22

Jack Bendheim · President, CEO and 10% owner

$570K−19.0%Jan 15

Jack Bendheim · President, CEO and 10% owner

$235K−9.0%Dec 15

Jack Bendheim · President, CEO and 10% owner

$193K−7.0%Dec 10

Jack Bendheim · President, CEO and 10% owner

$289K−10.0%Dec 4

Jack Bendheim · President, CEO and 10% owner

$296K−14.0%Dec 2

Jack Bendheim · President, CEO and 10% owner

$542K−20.0%Nov 26

Jack Bendheim · President, CEO and 10% owner

$147K−5.0%Nov 24

E Thomas Corcoran · Director

$111K+20.0%Feb 26

E Thomas Corcoran · Director

$100K+25.0%Sep 6

E Thomas Corcoran · Director

$118K+33.0%Sep 1

Larry Lee Miller · COO

$459K−40.0%Feb 10

E Thomas Corcoran · Director

$106K+50.0%Sep 4

Daniel M Bendheim · EVP, Corporate Strategy

$306K−100.0%Jan 30

Daniel M Bendheim · EVP, Corporate Strategy

$237K−100.0%Jan 24

Daniel M Bendheim · EVP, Corporate Strategy

$242K−100.0%Jan 18

Dean J Warras · Pres Animal Health, Nutr N.A.

$686K−100.0%Jan 17

Daniel M Bendheim · EVP, Corporate Strategy

$162K−100.0%Jan 10

Daniel M Bendheim · EVP, Corporate Strategy

$238K−100.0%Jan 7

Dean J Warras · Pres Animal Health, Nutr N.A.

$428K−100.0%Nov 5

Daniel M Bendheim · EVP, Corporate Strategy

$111K−100.0%Sep 14

Jack Bendheim · President, CEO and 10% owner

$943K−40.0%Sep 6

Bfi Co., LLC · 10% owner

$943K−40.0%Sep 6

Jack Bendheim · President, CEO and 10% owner

$1.5M−50.0%Aug 23

Bfi Co., LLC · 10% owner

$1.5M−50.0%Aug 23

Jack Bendheim · President, CEO and 10% owner

$1.5M−50.0%Aug 15

Bfi Co., LLC · 10% owner

$1.5M−50.0%Aug 15

Jack Bendheim · President, CEO and 10% owner

$1.5M−100.0%Aug 8

Bfi Co., LLC · 10% owner

$1.5M−100.0%Aug 8

Jack Bendheim · President, CEO and 10% owner

$568K−40.0%Jul 27

Bfi Co., LLC · 10% owner

$568K−40.0%Jul 27

Bfi Co., LLC · 10% owner

$837K−37.0%Jul 19

Jack Bendheim · President, CEO and 10% owner

$837K−37.0%Jul 19

About Phibro Animal Health Corporation

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.